Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-24-000317
Filing Date
2024-11-21
Accepted
2024-11-21 13:37:09
Documents
30
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cncl1119form10q.htm   iXBRL 10-Q 244652
2 EXHIBIT 31.1 cncl1119form10qexh31_1.htm EX-31.1 8167
3 EXHIBIT 31.2 cncl1119form10qexh31_2.htm EX-31.2 8113
4 EXHIBIT 32.1 cncl1119form10qexh32_1.htm EX-32.1 3872
  Complete submission text file 0001554795-24-000317.txt   1160145

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cncl-20240930.xsd EX-101.SCH 9995
6 XBRL CALCULATION FILE cncl-20240930_cal.xml EX-101.CAL 19178
7 XBRL DEFINITION FILE cncl-20240930_def.xml EX-101.DEF 10311
8 XBRL LABEL FILE cncl-20240930_lab.xml EX-101.LAB 95332
9 XBRL PRESENTATION FILE cncl-20240930_pre.xml EX-101.PRE 67488
33 EXTRACTED XBRL INSTANCE DOCUMENT cncl1119form10q_htm.xml XML 73291
Mailing Address 440 EAST 400 SOUTH STE 300 SALT LAKE CITY UT 84111
Business Address 440 EAST 400 SOUTH STE 300 SALT LAKE CITY UT 84111 801-323-2395
CANCER CAPITAL CORP (Filer) CIK: 0001130889 (see all company filings)

EIN.: 911803648 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32363 | Film No.: 241483425
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)